XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
1.730
+0.050 (2.98%)
At close: Nov 20, 2026, 4:00 PM EST
1.740
+0.010 (0.58%)
After-hours: Nov 20, 2026, 7:30 PM EST
XBiotech Market Cap
XBiotech has a market cap or net worth of $52.74 million as of November 20, 2026. It is the 29,120th most valuable company in the world and the 4,460th biggest in the United States. Its market cap has decreased by 19.96% in one year.
Market Cap
52.74M
Enterprise Value
-52.29M
1-Year Change
-19.96%
Global Rank
Country Rank
#4,460 United States
Category
ChartMarket Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $52.74M, a decrease of -92.85%. That is a compound annual growth rate of -20.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 52.74M | -27.65% |
| Dec 31, 2025 | 72.90M | -39.45% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
| Apr 15, 2015 (IPO) | 737.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 58.46M |
| Anavex Life Sciences | 57.76M |
| OKYO Pharma | 57.73M |
| Coherus Oncology | 57.04M |
| iBio, Inc. | 56.36M |
| Azora Therapeutics | 55.57M |
| Boundless Bio | 54.89M |
| Cognition Therapeutics | 53.91M |